SCHEMBL22609504

SCHEMBL22609504

O=C(O)NCCOCCOCC#Cc1cccc2c1c1cccnc1n2[C@H]1CCC(=O)NC1=O

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 19/20 0.55
CRBN Q96SW2 19/20 0.55
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21071152 1.00 DDB1 (0.55) DDB1CRBNEGFR
SCHEMBL21106382 0.90 DDB1 (0.69) DDB1CRBN
SCHEMBL29612727 0.90 DDB1 (0.69) DDB1CRBN
SCHEMBL22609557 0.89 DDB1 (0.59) DDB1CRBN
SCHEMBL21071143 0.89 DDB1 (0.59) DDB1CRBN
SCHEMBL31577925 0.86 DDB1 (0.51) DDB1CRBN
SCHEMBL21071349 0.85 DDB1 (0.67) DDB1CRBN
SCHEMBL22609360 0.85 DDB1 (0.67) DDB1CRBN
SCHEMBL22609591 0.85 DDB1 (0.61) DDB1CRBN
SCHEMBL21069275 0.85 DDB1 (0.61) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3731869-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2020-11-04 EP disclosed